title: Appropriate use of bioresorbable vascular scaffolds in percutaneous coronary interventions: a recommendation from experienced users : A position statement on the use of bioresorbable vascular scaffolds in the Netherlands.
abstract: Percutaneous coronary interventions (PCI) have become a reliable revascularisation option to treat ischaemic coronary artery disease. Drug-eluting stents (DES) are widely used as first choice devices in many procedures due to their established good medium to long term outcomes. These permanent implants, however, do not have any residual function after vascular healing following the PCI. Beyond this initial healing period, metallic stents may induce new problems, resulting in an average rate of 2 % reinterventions per year. To eliminate this potential late limitation of permanent metallic DES, bioresorbable coronary stents or 'vascular scaffolds' (BVS) have been developed. In a parallel publication in this journal, an overview of the current clinical performance of these scaffolds is presented. As these scaffolds are currently CE marked and commercially available in many countries and as clinical evidence is still limited, recommendations for their general usage are needed to allow successful clinical introduction.
authors: Thoraxcenter, Erasmus Medical Centre, 's-Gravendijkwal 230, 3015 GE, Rotterdam, The Netherlands, b.everaert@erasmusmc.nl.
authors: Bert
authors: B
authors: Everaert
authors: Cordula
authors: C
authors: Felix
authors: Jacques
authors: J
authors: Koolen
authors: Peter
authors: P
authors: den Heijer
authors: Jose
authors: J
authors: Henriques
authors: Joanna
authors: J
authors: Wykrzykowska
authors: Rene
authors: R
authors: van der Schaaf
authors: Bart
authors: B
authors: de Smet
authors: Sjoerd
authors: S
authors: Hofma
authors: Roberto
authors: R
authors: Diletti
authors: Nicolas
authors: N
authors: Van Mieghem
authors: Evelyn
authors: E
authors: Regar
authors: Peter
authors: P
authors: Smits
authors: Robert-Jan M
authors: RJ
authors: van Geuns
references: Circulation. 2012 Jan 31;125(4):584-91
references: 22203694
references: JAMA. 2013 Nov 20;310(19):2086-95
references: 24240936
references: Neth Heart J. 2014 Jan;22(1):3-10
references: 24343132
references: Neth Heart J. 2013 May;21(5):230-5
references: 23456884
references: J Am Coll Cardiol. 2014 Nov 18-25;64(20):2086-97
references: 25236346
references: N Engl J Med. 2007 Mar 8;356(10):998-1008
references: 17296824
references: Neth Heart J. 2015 Mar;23(3):153-60
references: 25626697
references: Circ Cardiovasc Interv. 2014 Feb;7(1):80-7
references: 24425588
references: N Engl J Med. 2009 Sep 10;361(11):1045-57
references: 19717846
references: JACC Cardiovasc Interv. 2013 Oct;6(10 ):999-1009
references: 24156961
references: Lancet. 2015 Jan 3;385(9962):43-54
references: 25230593
references: EuroIntervention. 2014 Mar 20;9(11):1271-84
references: 24291783
references: JACC Cardiovasc Interv. 2010 Oct;3(10):1051-8
references: 20965464
references: N Engl J Med. 2007 Nov 15;357(20):2001-15
references: 17982182
references: EuroIntervention. 2015 Feb;10(10):1154-9
references: 24647105